Founded in 2016, Quratis is a biotechnology company based in Seoul, South Korea. The company specializes in the development of vaccines and provides adjuvant platform technology designed to enhance the immune response to antigens. They also offer dendritic immune cell therapy for treating immune-related disorders. Quratis is engaged in the manufacture and sale of biopharmaceuticals, including peptide nucleic acid complexes and cell-penetrating peptides. They are committed to advancing global healthcare through innovative vaccine development.